BEONE MEDICINES LTD. (BEIGF) Operating margin 2016–2025
BEONE MEDICINES LTD. (BEIGF) operating margin by fiscal year — reported operating income divided by reported revenue.
8.4%FY2025 · since FY2016: -10940.2% → 8.4%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 8.4% | +23.3 pp |
| FY2024 | -14.9% | +34.2 pp |
| FY2023 | -49.1% | +77.3 pp |
| FY2022 | -126.4% | -4.1 pp |
| FY2021 | -122.3% | +414.4 pp |
| FY2020 | -536.7% | -312.5 pp |
| FY2019 | -224.2% | +131.9 pp |
| FY2018 | -356.1% | -314.8 pp |
| FY2017 | -41.3% | +10898.9 pp |
| FY2016 | -10940.2% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More BEIGF financial trends
BEIGF RevenueBEIGF Net incomeBEIGF Net marginBEIGF Gross profitBEIGF Gross marginBEIGF Operating incomeBEIGF Operating cash flowBEIGF Free cash flowBEIGF Capital expendituresBEIGF Return on equityBEIGF Stock buybacksBEIGF Dividends paidBEIGF Total assetsBEIGF Total liabilitiesBEIGF Shareholders’ equityBEIGF overview →